Objective
to report the 10-year all cause death of treatment with PCI or CABG in patients 3-VD or left main disease
Study
multicentre, randomised non-inferiority trial
Population
patients with 3-VD or left main disease eligible for either PCI or CABG
Endpoints
all-cause death at 10 years
Conclusion
there is no significant difference in all-cause death between PCI and CABG at 10 years. CABG is associated with lower 10-year mortality in patients with 3-vessel disease
Thuijs et al. Lancet. 2019;394:1324-34